English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Aims/Introduction  Type 2 diabetes is a worldwide disease that is associated with increased rates of obesity and reduced physical activity. Obesity‐associated insulin resistance in type 2 diabetes is a disorder in the balance between pro‐inflammatory and anti‐inflammatory signals. T cell immunoglobulin and mucin domain‐containing molecule 3 (Tim‐3) has been reported as an important regulatory inflammation molecule, and plays a pivotal role in several inflammation‐related diseases.    Materials and Methods  Peripheral blood mononuclear cells were obtained from type 2 diabetes patients ( n  = 31) and healthy donors ( n  = 18), and Tim‐3 expression on peripheral blood mononuclear cells was evaluated by flow cytometry.    Results  We showed the downregulated expression of Tim‐3 on  CD 14 +  monocytes from type 2 diabetes patients. In addition, the upregulated expression of Tim‐3 on peripheral  CD 4 +  T cells and  CD 8 +  T cells was observed in the present study. The correlation analysis between Tim‐3 expression on  CD 14 +  monocytes and diabetes duration showed the longer diabetes duration time, the lower Tim‐3 expression on  CD 14 monocytes.    Conclusions  The present results suggest that Tim‐3 might participate in the progression of type 2 diabetes by its negative regulation on these immune cells, and Tim‐3 on  CD 14 +  monocytes serves as a novel biological marker for diabetes duration in type 2 diabetes patients.

journal of diabetes investigation

T cell immunoglobulin and mucin domain‐containing molecule 3 on  CD 14 +  monocytes serves as a novel biological marker for diabetes duration in type 2 diabetes mellitus